Teva raises USD 4.9bn to refinance higher-coupon debt
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) priced a multi-tranche senior notes offering totaling approximately USD 4.9 billion equivalent, with...
Read full article →Business
Systematic, data-driven science coverage · Sunday, September 13, 2026
Most Read
Development
Insilico’s rentosertib becomes first AI-discovered drug to enter Phase III
Business
ViaNautis expands into spinal cord injury with SCI Ventures backing for polyNaut platform
Development
Disc Medicine’s DISC-3405 reduces phlebotomy needs in Phase II polycythemia vera trial
Business
Insightec spinout Lotus Neuro launches brain drug delivery platform
Development
AbbVie's atogepant meets primary endpoint in Phase III menstrual migraine trial
Business
1d agoIMUNON partners with National Cancer Institute to expand IL-12 DNA plasmid beyond ovarian cancer
New Jersey-based IMUNON, Inc. (Nasdaq: IMNN) entered a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part...
Business
1d agoExegenesis and Modalis combine muscle-targeting AAV with epigenome editing for preclinical DMD candidate
Exegenesis Bio and Japan-based Modalis Therapeutics Corporation (Tokyo: 4883) signed a research collaboration and license agreement to advance MDL-201, a...
Business
1d agoYarrow raises USD 150m to advance first-in-class Graves' disease antibody into Phase II
Connecticut-based Yarrow Bioscience, Inc. (Nasdaq: YARW) announced the pricing of an underwritten public offering of 5,769,231 shares of common stock at USD...
Business
2d agoNavion Neurosciences secures USD 10.8m to pursue sodium-channel drugs for epilepsy and pain
Charlottesville, Virginia-based Navion Neurosciences, Inc. announced first closing of a USD 10.8 million seed financing round to advance precision...
Business
2d agoEncoded Therapeutics raises USD 275m to push ETX101 toward pivotal Dravet syndrome trial
South San Francisco-based Encoded Therapeutics has closed a USD 275 million Series F financing round to advance its lead gene therapy candidate through...
Business
2d agoCONNECTA raises EUR 3.1m to advance TrkB modulator into mid-stage Fragile X trial
Barcelona-based CONNECTA Therapeutics has closed a EUR 3.1 million (USD 3.4 million) financing round to support the clinical development of CTH120, its...
Business
2d agoEthris secures EUR 30m to advance broad-spectrum nasal antiviral into Phase IIb trials
Germany-based Ethris GmbH has secured EUR 30 million to support the advance of its mRNA-based respiratory treatments into later-stage trials. The financing...
Business
2d agoCerenome secures USD 20m royalty-based financing to scale CNSide diagnostics platform
Houston-based Cerenome, Inc. (Nasdaq: CNSY) has secured a senior secured financing facility of up to USD 20 million from 3i, LP, structured with...
Business
2d agoThird Arc Bio advances first masked CD3 TCE under expanded Adagene collaboration
Third Arc Bio has selected its first lead candidate under an amended strategic collaboration with Adagene Inc. (Nasdaq: ADAG), triggering an expansion of...
Business
2d agoNeOnc raises USD 15m to advance Phase II CNS cancer programs after NEO100 efficacy readout
California-based NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) announced a USD 15 million registered direct offering on September 9, 2026, with proceeds...
Business
2d agoViaNautis expands into spinal cord injury with SCI Ventures backing for polyNaut platform
Cambridge, UK-based ViaNautis Bio has secured investment from SCI Ventures to expand its non-viral genetic medicine delivery platform into chronic spinal...
Business
2d agoMindera Health partners with UPenn to investigate quinacrine mechanism in lupus
Mindera Health is collaborating with University of Pennsylvania researchers to investigate why quinacrine helps some patients with cutaneous lupus—and...
Business
3d agoUpDoc receives up to USD 9.2m from ARPA-H for autonomous heart failure AI system
Palo Alto-based UpDoc has been selected as a lead performer in the Advanced Research Projects Agency for Health (ARPA-H) ADVOCATE program, receiving an...
Business
3d agoCytonics crowdfunds USD 4.8m to advance A2M biologic into Phase Ib/IIa osteoarthritis study
Jupiter, Florida-based Cytonics Corporation has completed a USD 4.8 million gross-proceeds financing campaign, bringing total capital raised to USD 47...
Business
3d agoInsightec spinout Lotus Neuro launches brain drug delivery platform
Lotus Neuro, a clinical-stage biotechnology company spun out of focused ultrasound specialist Insightec, launched publicly with a platform designed to...
The AllSci Brief
Free, systematic R&D and deal news. Daily.